Targeting Oxidative Stress with Antioxidant Duotherapy after Experimental Traumatic Brain Injury
We assessed the effect of antioxidant therapy using the Food and Drug Administration-approved respiratory drug <i>N</i>-acetylcysteine (NAC) or sulforaphane (SFN) as monotherapies or duotherapy in vitro in neuron-BV2 microglial co-cultures and validated the results in a lateral fluid-per...
Main Authors: | Jenni Kyyriäinen, Natallie Kajevu, Ivette Bañuelos, Leonardo Lara, Anssi Lipponen, Silvia Balosso, Elina Hämäläinen, Shalini Das Gupta, Noora Puhakka, Teemu Natunen, Teresa Ravizza, Annamaria Vezzani, Mikko Hiltunen, Asla Pitkänen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/19/10555 |
Similar Items
-
Treatment of Status Epilepticus after Traumatic Brain Injury Using an Antiseizure Drug Combined with a Tissue Recovery Enhancer Revealed by Systems Biology
by: Natallie Kajevu, et al.
Published: (2023-09-01) -
Gene Expression Profile as a Predictor of Seizure Liability
by: Anssi Lipponen, et al.
Published: (2023-02-01) -
Comparison of Pharmacokinetics and Anti-Pulmonary Fibrosis-Related Effects of Sulforaphane and Sulforaphane <i>N</i>-acetylcysteine
by: Eun Suk Son, et al.
Published: (2021-06-01) -
Discovery and Validation of Circulating microRNAs as Biomarkers for Epileptogenesis after Experimental Traumatic Brain Injury–The EPITARGET Cohort
by: Mette Heiskanen, et al.
Published: (2023-02-01) -
Plasma Neurofilament Light Chain (NF-L) Is a Prognostic Biomarker for Cortical Damage Evolution but Not for Cognitive Impairment or Epileptogenesis Following Experimental TBI
by: Mette Heiskanen, et al.
Published: (2022-12-01)